Form 8-K - Current report:
SEC Accession No. 0001104659-24-033015
Filing Date
2024-03-11
Accepted
2024-03-11 16:30:31
Documents
16
Period of Report
2024-03-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm248266d1_8k.htm   iXBRL 8-K 24895
2 EXHIBIT 99.1 tm248266d1_ex99-1.htm EX-99.1 83337
6 GRAPHIC image_001.jpg GRAPHIC 5503
  Complete submission text file 0001104659-24-033015.txt   300603

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA mbio-20240311.xsd EX-101.SCH 3021
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE mbio-20240311_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mbio-20240311_pre.xml EX-101.PRE 22363
17 EXTRACTED XBRL INSTANCE DOCUMENT tm248266d1_8k_htm.xml XML 3495
Mailing Address 377 PLANTATION STREET WORCESTER MA 01605
Business Address 377 PLANTATION STREET WORCESTER MA 01605 7816524500
MUSTANG BIO, INC. (Filer) CIK: 0001680048 (see all company filings)

EIN.: 473828760 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38191 | Film No.: 24738467
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)